Association of Antibiotics and Other Drugs with Clinical Outcomes in Metastatic Melanoma Patients Treated with Immunotherapy

Immune checkpoint inhibitors (ICIs) targeting the programmed cell death protein-1 (PD-1) and programmed cell death ligand-1 (PD-L1) have improved survival in many advanced cancers including advanced melanoma, renal cell, urothelial, and non-small-cell lung cancers. However, not all patients respond,...

Descripción completa

Detalles Bibliográficos
Autores principales: Angrish, Manish D., Agha, Arun, Pezo, Rossanna C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324393/
https://www.ncbi.nlm.nih.gov/pubmed/34336290
http://dx.doi.org/10.1155/2021/9120162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324393/
https://www.ncbi.nlm.nih.gov/pubmed/34336290
http://dx.doi.org/10.1155/2021/9120162

Ejemplares similares